Advertisement
Section edited by Edward Graviss, Eyal Oren & Anna Vassall
This section aims to publish studies looking at all aspects of of the prevention, diagnosis and management of tuberculosis and other mycobacterial diseases in humans, including HIV-associated tuberculosis, as well as related molecular genetics, pathophysiology, and epidemiology.
Research article
Understanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-trea...
BMC Infectious Diseases 2017 17:517
Published on: 25 July 2017
Research article
Stigma associated with tuberculosis (TB) has been an object of interest in several regions of the world. The behaviour presented by patients as a result of social discrimination has contributed to delays in di...
BMC Infectious Diseases 2017 17:510
Published on: 21 July 2017
Research article
The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights the need for more effective control strategies. A new regimen to treat MDR-TB that includes pyrazinamide (PZA) is current...
BMC Infectious Diseases 2017 17:491
Published on: 12 July 2017
Research article
Gene polymorphisms impact greatly on a person’s susceptibility to pulmonary tuberculosis (PTB). Macrophage receptor with collagenous structure (MARCO) and CD36 are two scavenger receptors (SRs) that can recogn...
BMC Infectious Diseases 2017 17:488
Published on: 11 July 2017
Research article
Studies focusing on pulmonary tuberculosis in advanced age (≥80 years) are lacking. This study aimed to explore treatment delay, outcomes and their predictors in this group.
BMC Infectious Diseases 2017 17:449
Published on: 24 June 2017
Research article
Patients with Mycobacterium avium complex (MAC) lung disease (LD) have a heterogeneous prognosis. This study aimed to develop and validate a prognostic scoring model for these patients using independent risk fact...
BMC Infectious Diseases 2017 17:436
Published on: 19 June 2017
Study protocol
Shortening the standard 6-month treatment for drug-susceptible pulmonary tuberculosis (DS-PTB) would be a major improvement for TB case management and disease control.
BMC Infectious Diseases 2017 17:435
Published on: 19 June 2017
Research article
The incidence of nontuberculous mycobacteria (NTM) infections is increasing worldwide, however formal evaluations of the epidemiology of NTM infections are limited. Understanding the trends and true prevalence...
BMC Infectious Diseases 2017 17:432
Published on: 15 June 2017
Research article
Residents in long-term care facilities (LTCFs) are vulnerable to tuberculosis (TB) transmission; however, to delineate possible routes of TB transmission in LTCFs is difficult. This study aimed to address the ...
BMC Infectious Diseases 2017 17:421
Published on: 13 June 2017
Case report
Extensively drug-resistant (XDR) tuberculosis (TB) and multidrug resistant (MDR)-TB with additional resistance to injectable agents or fluoroquinolones are challenging to treat due to lack of available, effect...
BMC Infectious Diseases 2017 17:417
Published on: 12 June 2017
Research article
Genitourinary tuberculosis is the third most common form of extrapulmonary tuberculosis. Diagnosis is difficult because of unspecific clinical manifestations and low accuracy of conventional tests. Unfortunate...
BMC Infectious Diseases 2017 17:390
Published on: 5 June 2017
Research article
Diabetes mellitus (DM) increases tuberculosis (TB) risk, and there is increasing concern over the public health implications of the convergence of these two epidemics. Screening for TB among people with DM is ...
BMC Infectious Diseases 2017 17:388
Published on: 2 June 2017
Research article
Harris County, Texas is the third most populous county in the United States and consistently has tuberculosis rates above the national average. Understanding jurisdictional epidemiologic characteristics for th...
BMC Infectious Diseases 2017 17:378
Published on: 31 May 2017
Research article
Drug-resistant tuberculosis, especially multidrug-resistant tuberculosis (MDR-TB), is a major public health problem. Effective management of MDR-TB relies on accurate and rapid diagnosis. In this study, we ass...
BMC Infectious Diseases 2017 17:379
Published on: 31 May 2017
Correspondence
Multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) represent an important challenge for global tuberculosis (TB) control. The high rates of MDR/RR-TB observed among re-treatment cases can ar...
BMC Infectious Diseases 2017 17:374
Published on: 30 May 2017
Research article
Foreign-born patients with tuberculosis (TB) may introduce globally disseminated isolates of Mycobacterium tuberculosis into large cities in Japan. The risk of dissemination of these isolates into local regions, ...
BMC Infectious Diseases 2017 17:365
Published on: 25 May 2017
Research article
Whereas high risk groups such as asylum seekers are systematically screened for active tuberculosis (TB) upon entry in Switzerland, this strategy does not apply to homeless persons despite a reported high risk...
BMC Infectious Diseases 2017 17:347
Published on: 16 May 2017
Research article
Strains of the Beijing genotype of Mycobacterium tuberculosis (MTB) are reportedly associated with the virulence of tuberculosis (TB) infection, unfavorable outcomes of anti-TB treatment, and the global TB pandem...
BMC Infectious Diseases 2017 17:344
Published on: 15 May 2017
Research article
Urine LAM testing has been approved by the WHO for use in hospitalised patients with advanced immunosuppression. However, sensitivity remains suboptimal. We therefore examined the incremental diagnostic sensit...
BMC Infectious Diseases 2017 17:339
Published on: 12 May 2017
Research article
Currently, there is limited data on the risk factors associated with treatment delay in tuberculous meningitis (TBM). This study aimed to assess the duration of delay in the treatment TBM and to investigate it...
BMC Infectious Diseases 2017 17:341
Published on: 12 May 2017
